Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Nakanishi ( (JP:7716) ) is now available.
Nakanishi Inc. has revised upward its consolidated financial forecasts for the first half and full year ending December 31, 2026, reflecting stronger expected performance. The company now projects modest increases in net sales, operating profit, ordinary profit, profit attributable to owners of the parent, EBITDA and earnings per share versus its February guidance.
The upgrade is driven mainly by the planned consolidation of U.S. medical device makers Acra Cut, Inc. and Intech, Inc. as second-tier subsidiaries from April through December 2026. By folding these businesses into its results without changing assumed foreign exchange rates, Nakanishi signals a more confident earnings outlook and a strategic expansion of its medical device footprint in overseas markets.
The most recent analyst rating on (JP:7716) stock is a Hold with a Yen2736.00 price target. To see the full list of analyst forecasts on Nakanishi stock, see the JP:7716 Stock Forecast page.
More about Nakanishi
Nakanishi Inc. is a Tokyo-listed manufacturer specializing in innovative grinding technology applied to dental, surgical and industrial devices. Its differentiated, world-class product lineup is sold in 145 countries, with a stated mission to advance medical care and improve quality of life through proprietary high-precision tools and solutions.
Average Trading Volume: 224,980
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen221.4B
See more data about 7716 stock on TipRanks’ Stock Analysis page.